Information about Ibti Pharma
My details
*
*
*

Ibti Pharma (SRL)

BE 0769.814.863

Rue de l'Espinette (C.) 216, 7033 Mons

Company information

Status
Active

Enterprise number

BE0769.814.863

VAT liability
Yes
Established
17-06-2021
Last balance sheet year
2024
Company size
Small 0 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Ibti Pharma

2024 2023 2022
Profit/Loss € 22,766 -64 % € 63,702 -68 % € 200,872
Equity € 287,439 9 % € 264,674 32 % € 200,972
Gross margin € 49,719 -39 % € 82,061 -70 % € 277,172

Publications from Ibti Pharma

Date Publication
03-06-2024 Resignations, Appointments (FR)
07-09-2021 Articles of Association (Translation, Coordination, Other Modifications, …) - Miscellaneous (FR)
21-06-2021 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Ibti Pharma?
The VAT number of Ibti Pharma is BE 0769.814.863.
Wat is the PEPPOL ID of Ibti Pharma?
There is no information available about the PEPPOL ID of Ibti Pharma or the company is not yet registered on the PEPPOL network.
When was Ibti Pharma founded?
Ibti Pharma was founded on 17-06-2021.
What is the address of Ibti Pharma?
The current registered office of Ibti Pharma is located at Rue de l'Espinette (C.) 216, 7033 Mons.
When was the last time Ibti Pharma filed their annual financial statements?
The most recent financial statements of Ibti Pharma were filed on 29-07-2025.
How many employees does Ibti Pharma have?
There are currently no employees working at Ibti Pharma or no workforce information is available.
What is the annual turnover of Ibti Pharma?
At the time of its most recent financial statements, Ibti Pharma did not publish any turnover figures. Ibti Pharma reported a gross margin of €49,718.50.

Sources